Yukari Manabe - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Public Health, Immunology

56 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zawedde-Muyanja S, Manabe YC, Cattamanchi A, Castelnuovo B, Katamba A. Patient and health system level barriers to and facilitators for tuberculosis treatment initiation in Uganda: a qualitative study. Bmc Health Services Research. 22: 831. PMID 35764982 DOI: 10.1186/s12913-022-08213-w  0.309
2021 Nakiyingi L, Bwanika JM, Ssengooba W, Mubiru F, Nakanjako D, Joloba ML, Mayanja-Kizza H, Manabe YC. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting. Bmc Infectious Diseases. 21: 63. PMID 33435896 DOI: 10.1186/s12879-020-05752-7  0.36
2020 Naggirinya AB, Mujugira A, Meya DB, Biraro IA, Mupere E, Worodria W, Manabe YC. Functional adrenal insufficiency among tuberculosis-human immunodeficiency virus co-infected patients: a cross-sectional study in Uganda. Bmc Research Notes. 13: 224. PMID 32307006 DOI: 10.1186/S13104-020-05064-8  0.355
2019 Shah M, Paradis S, Betz J, Beylis N, Bharadwaj R, Caceres T, Gotuzzo E, Joloba M, Mave V, Nakiyingi L, Nicol MP, Pradhan N, King B, Armstrong D, Knecht D, ... ... Manabe YC, et al. Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31560049 DOI: 10.1093/cid/ciz932  0.359
2019 Musaazi J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, Reynolds SJ, Manabe YC, Castelnuovo B. Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 23: 514-521. PMID 31064632 DOI: 10.5588/ijtld.18.0306  0.32
2019 Zawedde-Muyanja S, Manabe YC, Sewankambo NK, Nakiyingi L, Nakanjako D. Xpert MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 22: 1475-1480. PMID 30606320 DOI: 10.5588/ijtld.17.0460  0.372
2018 Olson A, Ragan EJ, Nakiyingi L, Lin N, Jacobson KR, Ellner JJ, Manabe YC, Sagar M. Pulmonary Tuberculosis is Associated with Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Co-Infected Ugandans. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 30063648 DOI: 10.1097/QAI.0000000000001823  0.354
2018 Worodria W, Ssempijja V, Hanrahan C, Ssegonja R, Muhofwa A, Mazapkwe D, Mayanja-Kizza H, Reynolds SJ, Colebunders R, Manabe YC. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ counts. Aids (London, England). PMID 30005014 DOI: 10.1097/Qad.0000000000001941  0.339
2018 Verma S, Du P, Nakanjako D, Hermans S, Briggs J, Nakiyingi L, Ellner JJ, Manabe YC, Salgame P. "Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets". Bmc Infectious Diseases. 18: 220. PMID 29764370 DOI: 10.1186/S12879-018-3127-4  0.326
2018 Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, ... ... Manabe YC, et al. Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29514175 DOI: 10.1093/cid/ciy179  0.332
2018 Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC. Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda. Bmc Infectious Diseases. 18: 87. PMID 29466946 DOI: 10.1186/s12879-018-2992-1  0.367
2017 Hermans SM, Babirye JA, Mbabazi O, Kakooza F, Colebunders R, Castelnuovo B, Sekaggya-Wiltshire C, Parkes-Ratanshi R, Manabe YC. Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study. Bmc Infectious Diseases. 17: 433. PMID 28622763 DOI: 10.1186/S12879-017-2534-2  0.37
2017 Rompalo A, Kikonyogo R, Hsieh Y, Manabe Y, Gaydos C, Parkes-Ratanshi R. P1.05 Current use and perceived obstacles to use of point-of-care tests in sub-saharan africa Sexually Transmitted Infections. 93. DOI: 10.1136/Sextrans-2017-053264.113  0.305
2016 Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F. Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial. The American Journal of Tropical Medicine and Hygiene. 95: 1265-1271. PMID 27928077 DOI: 10.4269/Ajtmh.16-0239  0.309
2015 Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC. Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology. Plos One. 10: e0133756. PMID 26222142 DOI: 10.1371/journal.pone.0133756  0.389
2015 Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, de Jong BC. High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals. Plos One. 10: e0132581. PMID 26176604 DOI: 10.1371/journal.pone.0132581  0.36
2015 Cox JA, Lukande RL, Kalungi S, Van Marck E, Van de Vijver K, Kambugu A, Nelson AM, Colebunders R, Manabe YC. Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults. Plos One. 10: e0123323. PMID 25897661 DOI: 10.1371/Journal.Pone.0123323  0.325
2015 Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC. Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. Bmc Infectious Diseases. 15: 62. PMID 25888317 DOI: 10.1186/s12879-015-0812-4  0.385
2015 Dharan NJ, Amisano D, Mboowa G, Ssengooba W, Blakemore R, Kubiak RW, Armstrong DT, Jones M, Manabe YC, Joloba ML, Ellner JJ, Dorman SE, Alland D. Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation. Journal of Clinical Microbiology. 53: 1258-63. PMID 25653410 DOI: 10.1128/JCM.03619-14  0.307
2015 Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, De Jong BC. High genotypic discordance of concurrent mycobacterium tuberculosis isolates from sputum and blood of HIV-infected individuals Plos One. 10. DOI: 10.1371/journal.pone.0132581  0.327
2014 Ssengooba W, Nakiyingi L, Armstrong DT, Cobelens FG, Alland D, Manabe YC, Dorman SE, Ellner JJ, Joloba ML. Clinical utility of a novel molecular assay in various combination strategies with existing methods for diagnosis of HIV-related tuberculosis in Uganda. Plos One. 9: e107595. PMID 25222866 DOI: 10.1371/journal.pone.0107595  0.355
2014 Manabe YC, Nonyane BA, Nakiyingi L, Mbabazi O, Lubega G, Shah M, Moulton LH, Joloba M, Ellner J, Dorman SE. Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda. Plos One. 9: e101459. PMID 25000489 DOI: 10.1371/journal.pone.0101459  0.364
2014 Jones-López E, Manabe YC, Palaci M, Kayiza C, Armstrong D, Nakiyingi L, Ssengooba W, Gaeddert M, Kubiak R, Almeida Júnior P, Alland D, Dietze R, Joloba M, Ellner JJ, Dorman SE. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. Journal of Clinical Microbiology. 52: 2513-20. PMID 24808236 DOI: 10.1128/JCM.00642-14  0.323
2014 Nakiyingi L, Moodley VM, Manabe YC, Nicol MP, Holshouser M, Armstrong DT, Zemanay W, Sikhondze W, Mbabazi O, Nonyane BA, Shah M, Joloba ML, Alland D, Ellner JJ, Dorman SE. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 270-9. PMID 24675585 DOI: 10.1097/Qai.0000000000000151  0.356
2014 Shah M, Ssengooba W, Armstrong D, Nakiyingi L, Holshouser M, Ellner JJ, Joloba M, Manabe YC, Dorman SE. Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. Aids (London, England). 28: 1307-14. PMID 24637544 DOI: 10.1097/QAD.0000000000000264  0.355
2013 Shah M, Dowdy D, Joloba M, Ssengooba W, Manabe YC, Ellner J, Dorman SE. Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda. Aids (London, England). 27: 2883-92. PMID 25119690 DOI: 10.1097/Qad.0000000000000008  0.329
2013 Nakiyingi L, Bwanika JM, Kirenga B, Nakanjako D, Katabira C, Lubega G, Sempa J, Nyesiga B, Albert H, Manabe YC. Clinical predictors and accuracy of empiric tuberculosis treatment among sputum smear-negative HIV-infected adult TB suspects in Uganda. Plos One. 8: e74023. PMID 24040151 DOI: 10.1371/journal.pone.0074023  0.382
2013 Sun D, Dorman S, Shah M, Manabe YC, Moodley VM, Nicol MP, Dowdy DW. Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults International Journal of Tuberculosis and Lung Disease. 17: 552-558. PMID 23485389 DOI: 10.5588/Ijtld.12.0627  0.318
2013 Hermans SM, Manabe YC, Kiragga AN, Hoepelman AI, Lange JM, van Leth F. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting. Antiviral Therapy. 18: 615-22. PMID 23423604 DOI: 10.3851/IMP2525  0.313
2012 Manabe YC, Worodria W, Cobelens F. Empirical tuberculosis treatment or improved diagnostics? [Correspondence]. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 16: 280. PMID 29070199 DOI: 10.5588/ijtld.11.0242  0.312
2012 Manabe YC, Worodria W, Cobelens F. Empirical tuberculosis treatment or improved diagnostics? The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 16: 280; author reply 28. PMID 22236934 DOI: 10.5588/Ijtld.11.0242  0.31
2011 Conesa-Botella A, Loembé MM, Manabe YC, Worodria W, Mazakpwe D, Luzinda K, Mayanja-Kizza H, Miri M, Mbabazi O, Koole O, Kestens L, Colebunders R. Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 463-8. PMID 21963941 DOI: 10.1097/Qai.0B013E31823801De  0.332
2011 Elbireer S, Guwatudde D, Mudiope P, Nabbuye-Sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Tropical Medicine & International Health : Tm & Ih. 16: 981-7. PMID 21585625 DOI: 10.1111/J.1365-3156.2011.02800.X  0.36
2011 Albert H, Ademun PJ, Lukyamuzi G, Nyesiga B, Manabe Y, Joloba M, Wilson S, Perkins MD. Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopy. Bmc Infectious Diseases. 11: 125. PMID 21569474 DOI: 10.1186/1471-2334-11-125  0.334
2011 Worodria W, Massinga-Loembe M, Mayanja-Kizza H, Namaganda J, Kambugu A, Manabe YC, Kestens L, Colebunders R. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clinical & Developmental Immunology. 2011: 758350. PMID 21197091 DOI: 10.1155/2011/758350  0.349
2010 Albert H, Manabe Y, Lukyamuzi G, Ademun P, Mukkada S, Nyesiga B, Joloba M, Paramasivan CN, Perkins MD. Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. Plos One. 5: e15206. PMID 21203398 DOI: 10.1371/journal.pone.0015206  0.321
2009 Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, Allen SS, Grosset JH, Jain SK, Lamichhane G, Manabe YC, McMurray DN, Nuermberger EL, Bishai WR. Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infection and Immunity. 77: 1230-7. PMID 19103767 DOI: 10.1128/Iai.01117-08  0.319
2009 Kesavan AK, Brooks M, Tufariello J, Chan J, Manabe YC. Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model Tuberculosis. 89: 17-21. PMID 18948063 DOI: 10.1016/j.tube.2008.08.004  0.324
2008 Page KR, Manabe YC, Adelakun A, Federline L, Cronin W, Campbell JD, Dorman SE. Timing of therapy for latent tuberculosis infection among immigrants presenting to a U.S. public health clinic: a retrospective study. Bmc Public Health. 8: 158. PMID 18474110 DOI: 10.1186/1471-2458-8-158  0.34
2008 Mendez S, Hatem CL, Kesavan AK, Lopez-Molina J, Pitt ML, Dannenberg AM, Manabe YC. Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits. Veterinary Immunology and Immunopathology. 122: 167-74. PMID 18155300 DOI: 10.1016/j.vetimm.2007.11.006  0.356
2008 Manabe YC, Kesavan AK, Lopez-Molina J, Hatem CL, Brooks M, Fujiwara R, Hochstein K, Pitt ML, Tufariello J, Chan J, McMurray DN, Bishai WR, Dannenberg AM, Mendez S. The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome. Tuberculosis (Edinburgh, Scotland). 88: 187-96. PMID 18068491 DOI: 10.1016/J.Tube.2007.10.006  0.447
2006 Tufariello JM, Mi K, Xu J, Manabe YC, Kesavan AK, Drumm J, Tanaka K, Jacobs WR, Chan J. Deletion of the Mycobacterium tuberculosis resuscitation-promoting factor Rv1009 gene results in delayed reactivation from chronic tuberculosis Infection and Immunity. 74: 2985-2995. PMID 16622237 DOI: 10.1128/Iai.74.5.2985-2995.2006  0.479
2006 Helke KL, Mankowski JL, Manabe YC. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinburgh, Scotland). 86: 337-48. PMID 16359922 DOI: 10.1016/j.tube.2005.09.001  0.335
2005 Page KR, Jedlicka AE, Fakheri B, Noland GS, Kesavan AK, Scott AL, Kumar N, Manabe YC. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific. Infection and Immunity. 73: 8369-80. PMID 16299335 DOI: 10.1128/Iai.73.12.8369-8380.2005  0.443
2005 Kesavan AK, Mendez SE, Hatem CL, Lopez-Molina J, Aird K, Pitt ML, Dannenberg AM, Manabe YC. Effects of dexamethasone and transient malnutrition on rabbits infected with aerosolized Mycobacterium tuberculosis CDC1551. Infection and Immunity. 73: 7056-60. PMID 16177392 DOI: 10.1128/Iai.73.10.7056-7060.2005  0.408
2004 Scott CP, Kumar N, Bishai WR, Manabe YC. Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. The American Journal of Tropical Medicine and Hygiene. 70: 144-8. PMID 14993625  0.737
2004 Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR. Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis. Infection and Immunity. 72: 1733-45. PMID 14977982 DOI: 10.1128/Iai.72.3.1733-1745.2004  0.378
2004 Dorman SE, Hatem CL, Tyagi S, Aird K, Lopez-Molina J, Pitt ML, Zook BC, Dannenberg AM, Bishai WR, Manabe YC. Susceptibility to tuberculosis: clues from studies with inbred and outbred New Zealand White rabbits. Infection and Immunity. 72: 1700-5. PMID 14977978 DOI: 10.1128/Iai.72.3.1700-1705.2004  0.432
2004 SCOTT CP, MANABE YC, BISHAI WR, KUMAR N. SHORT REPORT: MODULATION OF MYCOBACTERIUM TUBERCULOSIS INFECTION BY PLASMODIUM IN THE MURINE MODEL The American Journal of Tropical Medicine and Hygiene. 70: 144-148. DOI: 10.4269/Ajtmh.2004.70.144  0.727
2004 Dorman SE, Hatem CL, Tyagi S, Aird K, Lopez-Molina J, Pitt MLM, Zook BC, Dannenberg AM, Bishai WR, Manabe YC. Susceptibility to Tuberculosis: Clues from Studies with Inbred and Outbred New Zealand White Rabbits Infection and Immunity. 72: 3695-3695. DOI: 10.1128/Iai.72.6.3695.2004  0.302
2003 Manabe YC, Dannenberg AM, Tyagi SK, Hatem CL, Yoder M, Woolwine SC, Zook BC, Pitt ML, Bishai WR. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Infection and Immunity. 71: 6004-11. PMID 14500521 DOI: 10.1128/IAI.71.10.6004-6011.2003  0.442
2002 Scott CP, Dos Anjos Filho L, De Queiroz Mello FC, Thornton CG, Bishai WR, Fonseca LS, Kritski AL, Chaisson RE, Manabe YC. Comparison of C18-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil Journal of Clinical Microbiology. 40: 3219-3222. PMID 12202556 DOI: 10.1128/Jcm.40.9.3219-3222.2002  0.688
2002 Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, Ko C, Carpenter L, Mehrotra J, Manabe YC, Fleischmann RD, Bishai WR. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proceedings of the National Academy of Sciences of the United States of America. 99: 8330-5. PMID 12060776 DOI: 10.1073/Pnas.102055799  0.721
2002 Manabe YC, Scott CP, Bishai WR. Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG Infection and Immunity. 70: 1566-1570. PMID 11854245 DOI: 10.1128/Iai.70.3.1566-1570.2002  0.71
2001 Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nature Medicine. 6: 1327-9. PMID 11100115 DOI: 10.1038/82139  0.383
1999 Manabe YC, Saviola BJ, Sun L, Murphy JR, Bishai WR. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proceedings of the National Academy of Sciences of the United States of America. 96: 12844-8. PMID 10536010 DOI: 10.1073/Pnas.96.22.12844  0.363
Show low-probability matches.